Literature DB >> 19304978

Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative.

L Calza1, N Rosseti, C Biagetti, D Pocaterra, V Colangeli, R Manfredi.   

Abstract

The most serious adverse event caused by abacavir is the hypersensitivity reaction, which is usually associated with the presence of the human leukocyte antigen (HLA) subtype B*5701, as shown in recent studies. We describe the case of a 41-year-old Caucasian female patient, who tested HLA-B*5701 negative and developed fever and severe skin rash 10 weeks after the start of abacavir therapy. Similar reports suggest that not all severe abacavir-induced adverse events occur as a result of classic hypersensitivity reactions, and can present also in HLA-B*5701-negative patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304978     DOI: 10.1258/ijsa.2008.008318

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

Review 1.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV.

Authors:  Brittany Elizabeth Yee; Nghia Hoang Nguyen; Daniel Lee
Journal:  BMJ Case Rep       Date:  2014-05-05

Review 3.  Management of HIV infection in treatment-naive patients: a review of the most current recommendations.

Authors:  Sarita D Boyd
Journal:  Am J Health Syst Pharm       Date:  2011-06-01       Impact factor: 2.637

4.  HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.

Authors:  Catherine Butkus Small; David A Margolis; Mark S Shaefer; Lisa L Ross
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

5.  Low prevalence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation.

Authors:  Hongwei Zhang; Tong Zhang; Hongxin Zhao; Ning Han; Haiwei Zhou; Yun He; Qingxia Zhao; Hong Li; Huiqin Li; Mi Zhang; Jianjian Li; Yongtao Sun; Ke Zhao; Qing Liu; Zhiying Liu; Zhen Li; Wei Xia; Yun Lan; Haolan Hu; Weiping Cai; Hao Wu
Journal:  AIDS Res Ther       Date:  2015-08-19       Impact factor: 2.250

6.  Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients.

Authors:  David Brandariz; Alex Smithson; Vanesa Anton-Vazquez
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.